Skip to main content
Year archive

OSTEOPORE LIMITED — 2024 filings

All 87 regulatory filings released by OSTEOPORE LIMITED (OSX) in 2024, sourced directly from the official regulator.

87 Filings
2024 Period
2024 filings (87)
Filing Released Lang
OSX enters agreement to issue redeemable convertible notes 3 pages 363.0KB
Capital/Financing Update
2024-12-23 English
Results of General Meeting 3 pages 492.9KB
Declaration of Voting Results & Voting Rights Announcements
2024-12-22 English
Notice of General Meeting 54 pages 1.7MB
Proxy Solicitation & Information Statement
2024-11-20 English
Application for quotation of securities - OSX 7 pages 20.2KB
Share Issue/Capital Change
2024-11-18 English
Application for quotation of securities - OSX 7 pages 20.2KB
Share Issue/Capital Change
2024-11-14 English
Osteopore inks DKSH deal to sell ortho products in Singapore 5 pages 395.2KB
Capital/Financing Update
2024-11-05 English
OSX partners scientists to drive regeneration innovation 5 pages 344.8KB
Capital/Financing Update
2024-11-03 English
Application for quotation of securities - OSX 6 pages 18.2KB
Share Issue/Capital Change
2024-10-31 English
Activities Report September 2024 and Appendix 4C 18 pages 5.5MB
Interim / Quarterly Report
2024-10-30 English
Osteopore Secures Brazilian Craniofacial Distribution Deal 4 pages 381.6KB
Regulatory Filings
2024-10-23 English
Osteopore strikes collaboration with NASDAQ-listed CytoMed 6 pages 463.8KB
Capital/Financing Update
2024-10-16 English
Osteopore strikes scaffold-based iPSC deal with RxCell 5 pages 416.6KB
Regulatory Filings
2024-10-09 English
Osteopore to raise A$20m via redeemable convertible note 4 pages 385.6KB
Capital/Financing Update
2024-09-26 English
Revised Initial Director's Interest Notice - Yujing Lim 2 pages 175.8KB
Director's Dealing
2024-09-25 English
Initial Director's Interest Notice - Yujing Lim 2 pages 174.7KB
Director's Dealing
2024-09-24 English
Appointment of Executive Director - Dr Yujing Lim 2 pages 351.1KB
Board/Management Information
2024-09-23 English
Half Yearly Report and Accounts 28 pages 1.2MB
Interim / Quarterly Report
2024-08-29 English
OSX and University of Chile complete bone implant studies 3 pages 412.1KB
Regulatory Filings
2024-08-21 English
Activities Update Qtr Ending June 2024 and Appendix 4C 18 pages 16.3MB
Interim / Quarterly Report
2024-07-30 English
Application for quotation of securities - OSX 6 pages 18.2KB
Share Issue/Capital Change
2024-07-30 English
Ceasing to be a substantial holder 3 pages 1.6MB
Regulatory Filings
2024-07-25 English
Application for quotation of securities - OSX 6 pages 18.2KB
Share Issue/Capital Change
2024-07-16 English
Osteopore strikes Exclusive Distribution with Zimmer Biomet 3 pages 407.5KB
Capital/Financing Update
2024-07-15 English
Application for quotation of securities - OSX 6 pages 18.2KB
Share Issue/Capital Change
2024-07-10 English
Application for quotation of securities - OSX 6 pages 18.2KB
Share Issue/Capital Change
2024-07-02 English
Application for quotation of securities - OSX 6 pages 18.2KB
Share Issue/Capital Change
2024-06-25 English
Application for quotation of securities - OSX 6 pages 18.2KB
Share Issue/Capital Change
2024-06-18 English
Application for quotation of securities - OSX 6 pages 18.2KB
Share Issue/Capital Change
2024-06-11 English
A$18.7m Osteopore, NDCS and A*STAR project hits milestones 4 pages 417.3KB
Capital/Financing Update
2024-06-05 English
Application for quotation of securities - OSX 6 pages 18.2KB
Share Issue/Capital Change
2024-06-04 English
Results of Annual General Meeting 2 pages 413.7KB
Declaration of Voting Results & Voting Rights Announcements
2024-05-29 English
Application for quotation of securities - OSX 6 pages 18.2KB
Share Issue/Capital Change
2024-05-26 English
Options Exercised and Cleansing Notice 2 pages 336.8KB
Capital/Financing Update
2024-05-26 English
Application for quotation of securities - OSX 6 pages 18.2KB
Share Issue/Capital Change
2024-05-22 English
Options Exercised and Cleansing Notice 2 pages 336.9KB
Capital/Financing Update
2024-05-22 English
Becoming a substantial holder 2 pages 1.3MB
Regulatory Filings
2024-05-22 English
Ceasing to be a substantial holder 3 pages 544.0KB
Major Shareholding Notification
2024-05-19 English
Company Secretary Appointment/Resignation 2 pages 337.1KB
Board/Management Information
2024-05-19 English
Becoming a substantial holder 3 pages 779.4KB
Major Shareholding Notification
2024-05-16 English
Appendix 3Y - Change of Director's Interest Notice x 2 6 pages 261.4KB
Director's Dealing
2024-05-14 English
OSX and SingHealth partner on Global Centre of Excellence 6 pages 865.3KB
Regulatory Filings
2024-05-13 English
Application for quotation of securities - OSX 6 pages 18.8KB
Share Issue/Capital Change
2024-05-07 English
Notification regarding unquoted securities - OSX 7 pages 21.4KB
Share Issue/Capital Change
2024-05-07 English
Osteopore successfully raises A$2.9m from Entitlement Offer 3 pages 400.0KB
Capital/Financing Update
2024-05-06 English
Activities Update Qtr Ending March 2024 and Appendix 4C 18 pages 4.8MB
Interim / Quarterly Report
2024-04-29 English
Notice of Annual General Meeting 22 pages 1.1MB
AGM Information
2024-04-28 English
First-in-human clinical trials begin in Singapore 3 pages 355.1KB
Regulatory Filings
2024-04-22 English
Pause in Trading 1 page 118.7KB
Regulatory Filings
2024-04-22 English
Trading Halt 2 pages 798.4KB
Regulatory Filings
2024-04-22 English
Response to ASX Price and Volume Query 3 pages 925.6KB
Regulatory Filings
2024-04-22 English
Annual Report to Shareholders 70 pages 2.0MB
Annual Report
2024-04-15 English
Appendix 4G and Corporate Governance Statement 21 pages 615.2KB
Regulatory Filings
2024-04-15 English
Reinstatement to Official Quotation 1 page 423.6KB
Report Publication Announcement
2024-04-15 English
Response to ASX Query Letter 5 pages 1.0MB
Regulatory Filings
2024-04-14 English
Osteopore extends Bridging Loan maturity date 2 pages 481.3KB
Capital/Financing Update
2024-04-09 English
Annual General Meeting Date 2 pages 333.9KB
AGM Information
2024-04-07 English
Osteopore announces 97% take-up for Entitlement Offer 2 pages 338.0KB
Capital/Financing Update
2024-04-04 English
Update - Proposed issue of securities - OSX 63 pages 1.3MB
Capital/Financing Update
2024-04-04 English
Ceasing to be a substantial holder 2 pages 175.4KB
Major Shareholding Notification
2024-04-04 English
Replacement Prospectus for Renounceable Rights Issue 56 pages 1.3MB
Capital/Financing Update
2024-04-03 English
Update - Proposed issue of securities - OSX 63 pages 1.3MB
Capital/Financing Update
2024-04-03 English
Update to Replacement Prospectus for Entitlement Offer 3 pages 367.7KB
Capital/Financing Update
2024-04-02 English
Suspension from Quotation 1 page 99.3KB
Regulatory Filings
2024-04-01 English
Replacement Prospectus for Renounceable Rights Issue 55 pages 1.4MB
Capital/Financing Update
2024-04-01 English
Letter to Eligible Shareholders 4 pages 340.3KB
Capital/Financing Update
2024-04-01 English
OSX issues Replacement Prospectus for Entitlement Offer 3 pages 818.1KB
Capital/Financing Update
2024-04-01 English
Update - Proposed issue of securities - OSX 63 pages 1.3MB
Capital/Financing Update
2024-04-01 English
Suspension from Quotation 2 pages 726.6KB
Report Publication Announcement
2024-03-27 English
Osteopore secures Singapore and Vietnam market approvals 4 pages 365.1KB
Regulatory Filings
2024-03-26 English
Amendment - OSX Singapore and Vietnam market approvals 5 pages 374.2KB
Capital/Financing Update
2024-03-26 English
Osteopore progresses Australian bone scaffold trials 4 pages 363.0KB
Capital/Financing Update
2024-03-25 English
Prospectus despatched 4 pages 379.4KB
Capital/Financing Update
2024-03-18 English
Letter to Eligible Shareholders 4 pages 198.8KB
Capital/Financing Update
2024-03-18 English
Letter to Ineligible Shareholders 2 pages 139.8KB
Capital/Financing Update
2024-03-18 English
OSX Entitlement Offer to support growth 6 pages 401.0KB
Capital/Financing Update
2024-03-12 English
Prospectus for Renounceable Rights Issue 53 pages 1.2MB
Capital/Financing Update
2024-03-12 English
Proposed issue of securities - OSX 8 pages 28.8KB
Capital/Financing Update
2024-03-12 English
Update - Proposed issue of securities - OSX 62 pages 1.3MB
Capital/Financing Update
2024-03-12 English
Appendix 3Y - Change of Director's Interest Notice x 3 9 pages 301.1KB
Director's Dealing
2024-03-05 English
Completion of Consolidation of Capital 2 pages 365.0KB
Share Issue/Capital Change
2024-03-03 English
Update - Consolidation/Split - OSX 5 pages 19.4KB
Share Issue/Capital Change
2024-03-03 English
Appendix 4E Preliminary Final Report 12 pages 540.5KB
Annual Report
2024-02-28 English
OSX advances capital consolidation for long-term growth 3 pages 431.0KB
Capital/Financing Update
2024-02-20 English
Activities Update Qtr Ending December 2023 and Appendix 4C 15 pages 3.5MB
Interim / Quarterly Report
2024-01-30 English
OSX achieves 100k implants, to accelerate commercialisation 3 pages 390.4KB
Regulatory Filings
2024-01-28 English
Notice of General Meeting 13 pages 2.4MB
AGM Information
2024-01-22 English
Consolidation/Split - OSX 5 pages 29.0KB
Share Issue/Capital Change
2024-01-22 English